FindTrial
Sign In

Application of multimodal analgesia in transperineal template-guided prostate biopsy

Application of multimodal analgesia in transperineal template-guided prostate biopsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018470
Enrollment
Unknown
Registered
2018-09-20
Start date
2017-10-01
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Group 1:flurbiprofen
Group 2:normal saline

Sponsors

Clinical Medical College, Yangzhou University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) nodules were found by digital examination of rectum; (2) abnormal images of prostate revealed by ultrasound, CT and MRI examination; (3) prostate specific antigen (PSA); (4) PE 4 ~ 10 g/L, abnormal ratio of free PSA to total PSA or abnormal density value of PSA.

Exclusion criteria

Exclusion criteria: (1) previous history of prostate puncture biopsy; (2) chronic prostate/pelvic pain; (3) patients with severe cardiovascular and cerebrovascular diseases or with abnormal coagulation function; (4) psychiatric history; (5) severe urinary system infection; (6) history of ulcer; (7) patients with a history of analgesic drugs 24h before operation; (8) those who cannot complete the pain scale.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;visual numeric scale;—

Countries

China

Contacts

Public ContactDing Xue-fei

Clinical Medical College, Yangzhou University

xuefeid@126.com+86 18051061234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026